James Allison
14Patents
8h-index
13Co-inventors
69Inventor score
Filing activity: Dec 4, 1995 → Aug 27, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5811097A | Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling | Emerging Cross-Sectional Technologies | 214 | Expired |
| US6051227A | Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling | Chemistry; Metallurgy | 135 | Expired |
| US5855887A | Blockade of lymphocyte down-regulation associated with CTLA-4 signaling | Chemistry; Metallurgy | 79 | Expired |
| US8709417B2 | Combination immunotherapy for the treatment of cancer | Chemistry; Metallurgy | 26 | Active |
| US7229628B1 | Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling | Chemistry; Metallurgy | 21 | Expired |
| US9375475B2 | Combination immunotherapy for the treatment of cancer | Chemistry; Metallurgy | 17 | Active |
| US7919079B2 | Cancer immunotherapy compositions and methods of use | Human Necessities | 13 | Active |
| US9868961B2 | Methods and compositions for localized secretion of anti-CTLA-4 antibodies | Chemistry; Metallurgy | 9 | Active |
| US9447186B2 | Antibodies to human B7x for treatment of metastatic cancer | Chemistry; Metallurgy | 7 | Active |
| US10023637B2 | Combination immunotherapy for the treatment of cancer | Chemistry; Metallurgy | 5 | Active |
| US10167337B2 | Combination immunotherapy for the treatment of cancer | Chemistry; Metallurgy | 3 | Active |
| US7704701B2 | Diagnosis of prostate cancer with SPAS-1 cancer antigen | Chemistry; Metallurgy | 0 | Active |
| US12180277B2 | LILRB4-binding antibody and methods of use thereof | Physics | 0 | Active |
| US12221489B2 | Antibodies to human B7x for treatment of metastatic cancer | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.